Advanced Medical Solutions Group (AMS) Stock Overview
Develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
AMS Community Fair Values
See what 11 others think this stock is worth. Follow their fair value or set your own to get alerts.
Advanced Medical Solutions Group plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£2.17 |
| 52 Week High | UK£2.49 |
| 52 Week Low | UK£1.68 |
| Beta | 0.64 |
| 1 Month Change | -0.23% |
| 3 Month Change | -2.25% |
| 1 Year Change | 3.83% |
| 3 Year Change | -13.37% |
| 5 Year Change | -4.62% |
| Change since IPO | 76.42% |
Recent News & Updates
These 4 Measures Indicate That Advanced Medical Solutions Group (LON:AMS) Is Using Debt Reasonably Well
Dec 15Here's What Analysts Are Forecasting For Advanced Medical Solutions Group plc (LON:AMS) After Its Interim Results
Sep 21Recent updates
Shareholder Returns
| AMS | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.6% | -1.0% | -0.4% |
| 1Y | 3.8% | 10.9% | 20.3% |
Return vs Industry: AMS underperformed the UK Medical Equipment industry which returned 11% over the past year.
Return vs Market: AMS underperformed the UK Market which returned 19.6% over the past year.
Price Volatility
| AMS volatility | |
|---|---|
| AMS Average Weekly Movement | 3.9% |
| Medical Equipment Industry Average Movement | 5.3% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in GB Market | 11.2% |
| 10% least volatile stocks in GB Market | 2.5% |
Stable Share Price: AMS has not had significant price volatility in the past 3 months compared to the UK market.
Volatility Over Time: AMS's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1991 | 1,500 | Chris Meredith | www.admedsol.com |
Advanced Medical Solutions Group plc, together with its subsidiaries, develops, manufactures, and distributes products for the surgical, woundcare, and wound-closure markets in the United Kingdom, Germany, rest of Europe, the United States, and internationally. The company operates in two segments, Surgical and Woundcare. It offers surgical products, such as tissue adhesives, sutures, haemostats, internal fixation devices, infection control, and internal sealants under LiquiBand, RESORBA, LiquiBandFix8, LIQUIFIX, and Seal-G, Vitalitec, and ActivHeal brand names.
Advanced Medical Solutions Group plc Fundamentals Summary
| AMS fundamental statistics | |
|---|---|
| Market cap | UK£468.19m |
| Earnings (TTM) | UK£9.12m |
| Revenue (TTM) | UK£220.30m |
Is AMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AMS income statement (TTM) | |
|---|---|
| Revenue | UK£220.30m |
| Cost of Revenue | UK£105.33m |
| Gross Profit | UK£114.98m |
| Other Expenses | UK£105.85m |
| Earnings | UK£9.12m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Mar 18, 2026
| Earnings per share (EPS) | 0.042 |
| Gross Margin | 52.19% |
| Net Profit Margin | 4.14% |
| Debt/Equity Ratio | 27.0% |
How did AMS perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/23 17:42 |
| End of Day Share Price | 2026/01/23 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Advanced Medical Solutions Group plc is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Julie Simmonds | Canaccord Genuity |
| Keith Redpath | Cavendish |
